Advocacy organizations on both sides of the marijuana legalization debate have filed notices of intent to participate in a ...

Three Republican state attorneys general have filed a lawsuit challenging the federal cannabis rescheduling action announced ...

Three Republican attorneys general are asking a federal appeals court to block the Trump administration's push to reschedule certain medical cannabis products.

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP explain the approach and significance of the final order rescheduling cannabis from Schedule I to Schedule III of the Controlled ...

The move also essentially splits the cannabis market in states that have legalized weed for both medical and recreational consumers.

Michael Stonebarger sorts young cannabis plants at a marijuana farm in Grandview, Mo., in 2022. President Trump set the process in motion to ease federal restrictions on marijuana. But his order doesn ...

Attorneys general maintain that rescheduling the drug will have a negative impact on communities.

Don't hold your breath.

Federal cannabis policy moved from theory to action this spring, and three ETFs sit closest to the trade. The AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS), the Amplify Seymour Cannabis ETF ...

These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.

It isn't easy to find a marijuana company that can turn a profit.

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. President Donald Trump's ...